Galapagos NV
GLPG
$29.08
Share price
0.59%
Change (1 day)
-22.31%
Change (1 year)
Categories
P/S ratio for Galapagos NV (GLPG)
P/S ratio as of April 2024 (TTM): 7.56
According to Galapagos NV's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.56307. At the end of 2023 the company had a P/S ratio of 10.6.
P/S ratio history for Galapagos NV from 2015 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 10.6 | 92.2% |
| 2022 | 5.50 | -15.24% |
| 2021 | 6.48 | -45.53% |
| 2020 | 11.9 | -17.97% |
| 2019 | 14.5 | -2.73% |
| 2018 | 14.9 | -54.64% |
| 2017 | 32.9 | 54.13% |
| 2016 | 21.3 | -62.23% |
| 2015 | 56.5 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.78 | -50.08% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.55 | -39.78% | 🇺🇸 USA |
 AbbVie ABBV | 5.37 | -29.03% | 🇺🇸 USA |
 Sanofi SNY | 2.25 | -70.25% | 🇫🇷 France |
 Merck MRK | 5.28 | -30.23% | 🇺🇸 USA |
 AstraZeneca AZN | 4.63 | -38.83% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 2.15 | -71.63% | 🇬🇧 UK |
 Fortress Biotech
FBIO | 0.4119 | -94.55% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 0.9135 | -87.92% | 🇮🇱 Israel |